Evaluation of TTV replication as a biomarker of immune checkpoint inhibitors efficacy in melanoma patients. Pescarmona R, Mouton W, Walzer T, Dalle S, et al. PLoS One 2021;16:e0255972.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Pescarmona R, Mouton W, Walzer T, Dalle S, et al. Evaluation of TTV replication as a biomarker of immune checkpoint inhibitors efficacy in melanoma patients. PLoS One 2021;16:e0255972.
PMID: 34370787